世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000028866

眼科薬市場レポート2020−2030

Visiongain

Ophthalmic Drugs Market Report 2020-2030

発刊日 2020/11/26

言語英語

体裁PDF/704ページ

「PDF」版704ページ

0000028866

眼科薬市場レポート2020−2030
Ophthalmic Drugs Market Report 2020-2030

3,999 USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数5人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

適応別予測(ドライアイ、緑内障薬、網膜疾患薬、アレルギー、炎症&抗感染薬)、種類別(処方薬、OTC薬)、販売経路別(院内薬局、ドラッグストア、オンライン薬局)地域別、主要国別分析プラス主要眼科薬メーカー別分析、COVID-19回復シナリオ

  • Covid-19とその後の不況/経済回復が眼科薬市場に与える影響
  • 眼科薬に関して今後10年間で最も収益性が高い市場はどこか‐アメリカはまだこの市場で優位に立てるのでしょうか。
  • 新規眼科疾患の治療薬(緑内障治療、涙道手術、糖尿病性網膜症、その他の眼科疾患)および新規治療薬のうち、どれが最も効果的か、また今後10年間で最大の売れ筋はどれでしょうか。
  • 新たな合併、買収、共同事業のうち、現在の勢力図を変えるのはどれでしょうか。

眼科薬の世界市場は年々拡大を続けています。眼科薬市場における御社の競合メーカーは重要な事業機会から利益を得ようとしています‐それは何でしょうか、また御社はどのようにすればその恩恵に浴することができるのでしょうか。このレポートはそれを明らかにします。

この市場の全ての競合企業は今後10年間にわたって製品の承認という重要な課題に直面しようとしている今‐2015年から2021年までに主要メーカーが実行してきた基本戦略を把握することが重要です。

レポート詳細

目次

1. Report Overview
1.1 Global Ophthalmic Drugs Market Overview
1.2 Global Ophthalmic Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain

2. Introduction to Ophthalmic Drugs
2.1. The Pharmaceutical Industry: Very Brief Overview
2.2 Structure and Function of the Eyes
2.3 The Global Burden of Eye Disease
2.4 Vision Impairment
2.5 Ophthalmic Drugs: Market Segmentation
2.6 Glaucoma: A Major Cause of Vision Loss
2.6.1 A Classification of Glaucoma
2.6.2 Primary Open-Angle Glaucoma
2.6.3 Acute Angle-Closure Glaucoma
2.6.4 Congenital Glaucoma
2.6.5 Secondary Glaucoma
2.6.6 Normal-Tension Glaucoma
2.6.7 Ocular Hypertension
2.7 Risk Factors for Glaucoma
2.8 Diagnosis of Glaucoma
2.9 Drug Treatment of Glaucoma
2.10 Laser Treatment and Surgery for Glaucoma
2.11 Age-Related Macular Degeneration (AMD)
2.11.1 Dry (non-exudative) AMD
2.11.2 Wet (exudative) AMD
2.11.3 Risk Factors for AMD
2.11.4 Diagnosis of AMD
2.11.5 Treatment of AMD
2.12 Diabetic Retinopathy (DR)
2.12.1 Diagnosis of Diabetic Retinopathy
2.12.2 Treatment of Diabetic Retinopathy
2.13 Ocular Allergy and Allergic Conjunctivitis
2.13.1 Diagnosis of Ocular Allergy
2.13.2 Treatment of Ocular Allergy
2.14 Ocular Inflammatory Disease
2.14.1 Treatment of Ocular Inflammatory Disease
2.15 Eye Infections
2.15.1 Treatment of Eye Infections
2.16 Dry Eye Syndrome
2.16.1 Treatment of Dry Eye Syndrome
2.17 Phases of Clinical Trials
2.18 Impact of Covid-19 on Ophthalmic Drugs Market

3. Qualitative Analysis of the Ophthalmic Drugs Market, 2020-2030
3.1 Market Factors Influencing Ophthalmic Drugs
3.2 SWOT Analysis of the Global Ophthalmic Drugs Market, 2020-2030
3.2.1 Strengths
3.2.1.1 Strengths Healthy R&D Pipeline
3.2.1.2 Advances in Drug Delivery Technologies
3.2.1.3 Support for Reimbursement and Payment Approvals
3.2.1.4 Gene Therapy and RNAi Technology
3.2.1.5 New Ophthalmic Therapeutic Applications for Drugs
3.2.1.6 Development of Neuroprotective Anti-Glaucoma Medications
3.2.1.7 Biomarkers as Tools for Better Diagnosis and Treatment
3.2.2 Weaknesses
3.2.2.1 Low Levels of Patient Adherence to Treatment
3.2.2.2 High Treatment Burden on Patients and Healthcare Providers
3.2.2.3 Under-Diagnosis and Under-Treatment
3.2.3 Opportunities
3.2.3.1 Sustained-Release Ocular Implants
3.2.3.2 The Impact of a Rapidly Ageing Global Population
3.2.3.3 Increasing Prevalence of Diabetes and Ocular Disease
3.2.3.4 Glaucoma and Retinal Disorders Set for Most-Marked Increases in Prevalence
3.2.3.5 Unmet Clinical Need in Many Disease Areas
3.2.3.6 Economic Growth in Emerging Market Provide Opportunity for Expansion
3.2.4 Threats
3.2.4.1 Intensifying Price Regulation in The Market
3.2.4.2 Generic Competition - Likely to Cause Erosion of Sales for Market Leading Brands
3.2.4.3 Rising Cost Of R&D
3.2.4.4 Biosimilars - A Bigger Threat than Generics?
3.3 Porter’s Five Force Analysis of The Global Ophthalmic Drugs Market, 2020-2029
3.3.1 Threat of New Entrants
3.3.2 Rivalry Among Competitors
3.3.3 Power of Suppliers
3.3.4 Power of Buyers
3.3.5 Power of Buyers
3.4 PESTEL Analysis

4. Ophthalmic Drugs Market, 2020-2030
4.1 Global Ophthalmic Drugs Market Overview
4.2 Categorisation of the Global Ophthalmic Drugs Market
4.3 Global Ophthalmic Drugs Market Overview
4.4 Global Ophthalmic Drugs Market: Revenue Forecast 2020-2030
4.5 Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.1 Pre-Covid Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.5.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6 Global Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
4.6.1 Pre-Covid Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
4.6.6 Pre-Covid Prescription Drugs: Revenue Forecast, 2020-2030
4.6.7 V-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.8 U-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.9 L-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.10 W-Shaped Recovery Prescription Drugs: Revenue Forecast, 2020-2030
4.6.11 Pre-Covid OTC Drugs: Revenue Forecast, 2020-2030
4.6.12 V-Shaped Recovery OTC Drugs: Revenue Forecast, 2020-2030
4.6.13 U-Shaped Recovery OTC Drugs: Revenue Forecast, 2020-2030
4.6.14 L-Shaped Recovery OTC Drugs: Revenue Forecast, 2020-2030
4.6.15 W-Shaped RecoveryOTC Drugs: Revenue Forecast, 2020-2030
4.7 4.7 Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.1 Pre-Covid Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
4.7.6 Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.1 Pre-Covid Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.2 V-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.3 U-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.4 L-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.6.5 W-Shaped Recovery Hospital Pharmacies: Revenue Forecast, 2020-2030
4.7.7 4.7.7 Drug Stores: Revenue Forecast, 2020-2030
4.7.7.1 Pre-Covid Drug Stores: Revenue Forecast, 2020-2030
4.7.7.2 V-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.7.3 U-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.7.4 4L-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.7.5 W-Shaped Recovery Drug Stores: Revenue Forecast, 2020-2030
4.7.8 4.7.8 Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.1 Pre-Covid Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.2 V-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.3 U-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.4 L-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.7.8.5 W-Shaped Recovery Online Pharmacies: Revenue Forecast, 2020-2030
4.8 Covid-19 Impact on Ophthalmic Drugs Market

** This section includes the ophthalmic drugs market size and forecast by indication, by type, by distribution channel. The section also includes different types of recoveries (V,U,L,W) by the market post COVID-19

5. Retinal Disorder Drugs Market, 2020-2030
5.1 Global Retinal Disorder Drugs Market Overview
5.1.1 Eylea & Lucentis losing patent is expected to hamper the growth of retinal disorder drugs market in the forecast, however new drugs BEOVU and other drugs market share is expected to increase
5.2 Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.1 Pre-Covid Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.2 V-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.3 U-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.4 L-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.2.5 W-Shaped Recovery Global Retinal Disorder Drugs Market: Revenue Forecast 2020-2030
5.3 Trend of Retinal Diseases in Developing Countries
5.4 Has Monotherapy Reached Its Limit?
5.5 Technologies that could transform the treatment of blindness
5.5.1 How Likely Is Avastin’s Expansion into Age-Related Macular Degeneration?
5.6 Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.6.1 Pre-Covid Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.7 Eylea (aflibercept) - Regeneron/ Bayer/ Santen: Revenue Forecast, 2020-2030
5.7.1 Eylea/Zaltrap and the Davis-Smyth Patent Agreements
5.7.2 Possible Combination Therapies Involving Eylea
5.8 Lucentis (ranibizumab) - Roche/ Novartis: Revenue Forecast, 2020-2030
5.8.1 Lucentis Approvals for New Indications
5.9 Avastin (bevacizumab) - Roche: Revenue Forecast, 2020-2030
5.9.1 Very low-dose Avastin may help prevent retinopathy of prematurity
5.9.2 Avastin Repackages Must Meet New Guidance
5.10 Visudyne (verteporfin) - Valeant/ Novartis: Revenue Forecast, 2020-2030
5.11 Jetrea (ocriplasmin) - ThromboGenics/ Novartis: Revenue Forecast, 2020-2030
5.12 BEOVU (brolucizumab-dbll): Revenue Forecast, 2020-2030
5.13 Other Retinal Disorder Drugs
5.13.1 Iluvien (fluocinolone implant) - Alimera Sciences
5.13.2 Ozurdex (dexamethasone implant) - Allergan
5.14 Covid-19 Impact on Retinal Disorder Drugs Market
5.14.1 V-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.14.2 U-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.14.3 L-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030
5.14.4 W-Shaped Recovery Global Retinal Disorder Drugs Market, By Drugs: Market Forecast 2020-2030

** This section includes the market size and forecast for retinal disorder drugs (Eylea, Lucentis, Avastin, Visudyne, Jetrea, BEOVU, Others) and rational behind there growth/decline of the market in the forecast period

6. Allergic, Inflammatory & Infective Drugs Market, 2020-2030
6.1 Global Allergic, Inflammatory & Infective Drugs Market Overview
6.1.1 Increasing prevalence of inflammatory diseases & changing lifestyle is expected to drive the growth of the segment in the forecast period
6.2 Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.1 Pre-Covid Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.2 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.3 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.4 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.2.5 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market: Revenue Forecast 2020-2030
6.3 Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.4 Patanol And Pataday (olopatadine) - Alcon (Novartis)
6.4.1 Pataday: Revenue Forecast, 2020-2030
6.4.2 Patanol: Revenue Forecast, 2020-2030
6.4.3 Approval of Pazeo Solution
6.5 Vigamox (moxifloxacin) - Alcon (Novartis): Revenue Forecast, 2020-2030
6.5.1 Intensifying Competition and Generics Drug Challenge to Vigamox
6.6 6TobraDex (tobramycin/dexamethasone) - Eyevance Pharmaceuticals: Revenue Forecast, 2020-2030
6.7 Cravit (levofloxacin) - Santen: Revenue Forecast, 2020-2030
6.8 Acular (ketorolac) - Allergan: Revenue Forecast, 2020-2030
6.9 AzaSite (azithromycin): Revenue Forecast, 2020-2030
6.10 Bromday (bromfenac): Revenue Forecast, 2020-2030
6.11 Covid-19 Impact on Allergic, Inflammatory & Infective Drugs Market
6.11.1 V-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.11.2 U-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.11.3 L-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030
6.11.4 W-Shaped Recovery Global Allergic, Inflammatory & Infective Drugs Market, By Drugs: Market Forecast 2020-2030

** This section includes the market size and forecast for Allergic, Inflammatory & Infective Drugs (Pataday, Vigamox, Patanol, TobraDex, Cravit, Acular, AzaSite, Bromday and Others) and revenue forecast for each drugs and different scenarios of the market recovery in the forecast period

7. Glaucoma Drugs Market, 2020-2030
7.1 Global Glaucoma Drugs Market Overview
7.1.1 Rising number of elderly and diabetics on a global scale
7.1.2 Numerous products in the development pipeline to help expand the market in the forecast period
7.2 Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.1 Pre-Covid Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.2 V-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.3 U-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.4 L-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.2.5 W-Shaped Recovery Global Glaucoma Drugs Market: Revenue Forecast 2020-2030
7.3 Pre-Covid Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.4 Glaucoma Drugs: Market Trends and Developments, 2020
7.4.1 Patent Expiration: A Major Restraint for Glaucoma Drugs
7.4.2 Innovation in Glaucoma Management
7.5 Lumigan & Ganfort (bimatoprost) - Allergan (Actavis): Revenue Forecast, 2020-2030
7.6 Travatan/Travatan Z & Duotrav (travoprost) - Novartis: Revenue Forecast, 2020-2030
7.7 Alphagan & Combigan: Revenue Forecast, 2020-2030
7.8 Xalatan & Xalacom (latanoprost) - Pfizer: Revenue Forecast, 2020-2030
7.9 Azopt (brinzolamide) - Novartis: Revenue Forecast, 2020-2030
7.10 Cosopt/ Cosopt PF: Revenue Forecast, 2020-2030
7.11 Tapros (tafluprost) - Santen: Revenue Forecast, 2020-2030
7.12 Trusopt: Revenue Forecast, 2020-2030
7.13 Zioptan (Tafluprost): Revenue Forecast, 2020-2030
7.14 Rhopressa (netarsudil): Revenue Forecast, 2020-2030
7.15 Covid-19 Impact on Glaucoma Drugs Market
7.15.1 V-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.15.2 U-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.15.3 L-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030
7.15.4 W-Shaped Recovery Global Glaucoma Drugs Market, By Drugs: Market Forecast 2020-2030

** This section includes the market size and forecast for Glaucoma Drugs (Lumigan & Ganfort, Travatan & Duotrav, Alphagan & Combigan, Xalatan & Xalacom, Azopt, Cosopt, Tapros, Trusopt, Zioptan, Rhopressa and Others) and revenue forecast for each drugs and different scenarios of the market recovery in the forecast period

8. Dry Eye Drugs Market, 2020-2030
8.1 Global Dry Eye Drugs Market Overview
8.1.1 Patent expire of Restasis expected to hamper the market growth
8.2 Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.1 Pre-Covid Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.2 V-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.3 U-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.4 L-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.2.5 W-Shaped Recovery Global Dry Eye Drugs Market: Revenue Forecast 2020-2030
8.3 Pre-Covid Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.4 Dry Eye Drugs: Market Trends and Developments, 2020
8.4.1 Restasis: Patent Elongations and Generic Challenges Creating Uncertainty
8.4.2 Concept of new dry eye diagnosis: tear film-oriented diagnosis
8.5 Restasis: Revenue Forecast, 2020-2030
8.6 Refresh: Revenue Forecast, 2020-2030
8.7 Hyalein: Revenue Forecast, 2020-2030
8.8 Diquas: Revenue Forecast, 2020-2030
8.9 Artelac (Hypromellose) - Bausch + Lomb: Revenue Forecast, 2020-2030
8.10 Others Dry Eye Drugs: Revenue Forecast, 2020-2030
8.11 Covid-19 Impact on Dry Eye Drugs Market
8.11.1 V-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.11.2 U-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.11.3 L-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030
8.11.4 W-Shaped Recovery Global Dry Eye Drugs Market, By Drugs: Market Forecast 2020-2030

** This section includes the market size and forecast for dry eye drugs (Restasis, Refresh, Hyalein, Diquas, Artelac, Others) and rational behind there growth/decline of the market in the forecast period

9. Ophthalmic Drugs Market, 2020-2030, By Region
9.1 Global Ophthalmic Drugs Market Overview
9.2 Pre-Covid Global Ophthalmic Drugs Market: Revenue Forecast 2020-2030
9.3 Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.1 Pre-Covid Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.2 V-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.3 U-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.4 L-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030
9.3.5 W-Shaped Recovery Global Ophthalmic Drugs Market, By Region: Market Forecast 2020-2030

** This section includes the market size and forecast for by region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa)

10. North America Ophthalmic Drugs Market, 2020-2030
10.1 North America Ophthalmic Drugs Market Overview
10.2 North America Ophthalmic Drugs Market: Revenue Forecast 2020-2030
10.3 North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.1 Pre-Covid North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.2 V-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.3 U-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.4 L-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.3.5 W-Shaped Recovery North America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
10.4 North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.1 Pre-Covid North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.2 V-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.3 U-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.4 L-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.4.5 W-Shaped Recovery North America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
10.5 North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.1 Pre-Covid North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.2 V-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.3 U-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.4 L-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.5.5 W-Shaped Recovery North America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
10.6 North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.6.1 Pre-Covid North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.6.2 U.S. Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
10.6.2.1 Is there a big change around the corner?
10.6.2.2 Rising geriatric population and chronic disease prevalence are some of the most important drivers of this market
10.6.3 Canada Ophthalmic Drugs: Revenue Forecast, 2020-2030
10.6.3.1 Increase concern and incidence of eye diseases in the country
10.6.3.2 New Drug Approvals
10.7 Covid-19 Impact on North America Ophthalmic Drugs Market
10.7.1 V-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.1.1 V-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.1.2 V-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
10.7.2 U-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.2.1 U-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.2.2 U-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
10.7.3 L-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.3.1 L-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.3.2 L-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030
10.7.4 W-Shaped Recovery North America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
10.7.4.1 W-Shaped Recovery US Ophthalmic Drugs Market: Forecast 2020-2030
10.7.4.2 W-Shaped Recovery Canada Ophthalmic Drugs Market: Forecast 2020-2030

** This section includes the detailed analysis of North America ophthalmic drugs market size and forecast for by indication, by type, by distribution channel and by country (U.S. & Canada)

11. Europe Ophthalmic Drugs Market, 2020-2030
11.1 Europe Ophthalmic Drugs Market Overview
11.2 Europe Ophthalmic Drugs Market: Revenue Forecast 2020-2030
11.3 Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.1 Pre-Covid Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.2 -Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.3 U-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.4 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.3.5 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
11.4 Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.1 Pre-Covid Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.2 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.3 U-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.4 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.4.5 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
11.5 Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.1 Pre-Covid Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.2 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.3 U-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.4 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.5.5 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
11.6 Pre-Covid Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.6.1 Germany Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.1.1 Adoption of technology for test patient for eye diseases is expected to increase awareness and expected to help ophthalmic drugs
11.6.2 France Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.6.2.1 Trend towards the removal of reimbursement for ophthalmic drugs from social security that restrict growth
11.6.3 U.K. Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.3.1 Reported uptake of screening for DED was highest in the UK
11.6.4 Italy Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.6.5 Spain Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.5.1 Aging popul ation and growing awareness is expected to drive the growth of the market
11.6.6 Russia Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.6.6.1 Cataract is responsible for half of reversible blindness on the planet
11.6.7 Poland Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
11.6.7.1 Increasing partnership in the ophthalmic drugs
11.6.8 Rest of Europe Ophthalmic Drugs: Revenue Forecast, 2020-2030
11.7 Covid-19 Impact on Europe Ophthalmic Drugs Market
11.7.1 V-Shaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.1.1 V-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.2 V-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.3 V-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.4 V-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.5 V-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.6 V-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.7 V-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.1.8 V-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2 UShaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.2.1 U-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.2 U-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.3 U-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.4 U-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.5 U-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.6 U-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.7 U-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.2.8 U-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3 L-Shaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.3.1 L-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.2 L-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.3 L-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.4 L-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.5 L-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.6 L-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.7 L-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.3.8 L-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4 W-Shaped Recovery Europe Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
11.7.4.1 W-Shaped Recovery Germany Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.2 W-Shaped Recovery France Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.3 W-Shaped Recovery U.K. Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.4 W-Shaped Recovery Italy Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.5 W-Shaped Recovery Spain Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.6 W-Shaped Recovery Russia Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.7 W-Shaped Recovery Poland Ophthalmic Drugs Market: Forecast 2020-2030
11.7.4.8 W-Shaped Recovery Rest of Europe Ophthalmic Drugs Market: Forecast 2020-2030

** This section includes the detailed analysis of Europe ophthalmic drugs market size and forecast for by indication, by type, by distribution channel and by country (Germany, France, United Kingdom, Italy, Spain, Russia, Poland, Rest of Europe)

12. Asia Pacific Ophthalmic Drugs Market, 2020-2030
12.1 Asia Pacific Ophthalmic Drugs Market Overview
12.2 Asia Pacific Ophthalmic Drugs Market: Revenue Forecast 2020-2030
12.3 Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.1 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.2 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.3 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.4 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.3.5 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
12.4 Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.1 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.2 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.3 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.4 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.4.5 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
12.5 Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.1 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.2 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.3 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.4 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.5.5 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
12.6 Pre-Covid Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.6.1 China Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
12.6.1.1 Expansion of Healthcare Coverage and Reimbursement in China
12.6.1.2 Looming crunch for public health insurance
12.6.1.3 Pharmaceutical Pricing Policies in China
12.6.2 Japan Ophthalmic Drugs: Revenue Forecast, 2020-2030
12.6.2.1 Pharmaceutical Policies and Reform in Japan
12.6.3 India Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
12.6.3.1 India: price controls and generic competition
12.6.3.2 Changing Healthcare infrastructure in India
12.6.4 Australia Ophthalmic Drugs: Revenue Forecast, 2020-2030
12.6.4.1 Long-term eye conditions and growing investment in evidence-based prevention
12.6.5 South Korea Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
12.6.5.1 Increasing prevalence of glaucoma and other eye related disorders.
12.6.6 Rest of Asia Pacific Ophthalmic Drugs: Revenue Forecast, 2020-2030
12.7 Covid-19 Impact on Asia Pacific Ophthalmic Drugs Market
12.7.1 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.2 U-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.3 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.4 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.5 V-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.5.1 V-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.5.2 V-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.5.3 V-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.5.4 V-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.5.5 V-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.5.6 V-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030
12.7.6 UShaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.6.1 U-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.6.2 U-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.6.3 12.7.2.3 U-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.6.4 U-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.6.5 U-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.6.6 U-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030
12.7.7 L-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.7.1 L-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.7.2 L-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.7.3 L-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.7.4 L-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.7.5 L-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.7.6 L-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030
12.7.8 W-Shaped Recovery Asia Pacific Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
12.7.8.1 W-Shaped Recovery China Ophthalmic Drugs Market: Forecast 2020-2030
12.7.8.2 W-Shaped Recovery Japan Ophthalmic Drugs Market: Forecast 2020-2030
12.7.8.3 W-Shaped Recovery India Ophthalmic Drugs Market: Forecast 2020-2030
12.7.8.4 W-Shaped Recovery Australia Ophthalmic Drugs Market: Forecast 2020-2030
12.7.8.5 W-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
12.7.8.6 W-Shaped Recovery Rest of Asia PacificOphthalmic Drugs Market: Forecast 2020-2030

** This section includes the detailed analysis of Asia Pacific ophthalmic drugs market size and forecast for by indication, by type, by distribution channel and by country (China, Japan, India, Australia, South Korea, Rest of Asia Pacific)

13. Latin America Ophthalmic Drugs Market, 2020-2030
13.1 Latin America Ophthalmic Drugs Market Overview
13.2 Latin America Ophthalmic Drugs Market: Revenue Forecast 2020-2030
13.3 Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.1 Pre-Covid Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.2 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.3 U-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.4 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.3.5 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
13.4 Latin America Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.1 Pre-Covid Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.2 V-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.3 U-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.4 L-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.4.5 W-Shaped Recovery Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
13.5 Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.1 Pre-Covid Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.2 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.3 U-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.4 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.5.5 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
13.6 Pre-Covid Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.6.1 Brazil Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
13.6.1.1 Increasing the prevalence of ophthalmic conditions and increasing government spending on health care
13.6.2 Mexico Ophthalmic Drugs: Revenue Forecast, 2020-2030
13.6.2.1 Chronic diseases such as diabetes mellitus, cardiovascular disease, and hypertension have consequences on visual health and increase the risk of visually impeding cataracts.
13.6.3 Rest of Latin America Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
13.7 Covid-19 Impact on Latin America Ophthalmic Drugs Market
13.7.1 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.2 U-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.3 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.4 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.5 V-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.5.1 V-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.5.2 V-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.5.3 V-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
13.7.6 UShaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.6.1 U-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.6.2 U-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.6.3 U-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
13.7.7 L-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.7.1 L-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.7.2 L-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.7.3 L-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030
13.7.8 W-Shaped Recovery Latin America Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
13.7.8.1 W-Shaped Recovery Brazil Ophthalmic Drugs Market: Forecast 2020-2030
13.7.8.2 W-Shaped Recovery Mexico Ophthalmic Drugs Market: Forecast 2020-2030
13.7.8.3 W-Shaped Recovery Rest of Latin America Ophthalmic Drugs Market: Forecast 2020-2030

** This section includes the detailed analysis of Latin America ophthalmic drugs market size and forecast for by indication, by type, by distribution channel and by country (Brazil, Mexico and Rest of Latin America)

14. Middle East & Africa Ophthalmic Drugs Market, 2020-2030
14.1 Middle East & Africa Ophthalmic Drugs Market Overview
14.2 Middle East & Africa Ophthalmic Drugs Market: Revenue Forecast 2020-2030
14.3 Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.1 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.2 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.3 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.4 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.3.5 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Indication: Market Forecast 2020-2030
14.4 Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.1 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.2 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.3 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.4 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.4.5 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Type: Market Forecast 2020-2030
14.5 Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.1 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.2 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.3 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.4 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.5.5 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Distribution Channel: Market Forecast 2020-2030
14.6 Pre-Covid Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.6.1 Saudi Arabia Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
14.6.1.1 Ecological and socio-economical determinants play critical role in the magnitude and causes of blindness and visual impairment
14.6.2 South Africa Ophthalmic Drugs: Revenue Forecast, 2020-2030
14.6.2.1 South Africa: has the Single Exit Price worked?
14.6.2.2 Increased investment in health care provision and infrastructure development would lead to high demand for ophthalmic drugs market
14.6.3 UAE Ophthalmic Drugs Market: Revenue Forecast, 2020-2030
14.6.3.1 Government initiatives and growing awareness
14.6.4 Rest of Middle East & Africa Ophthalmic Drugs: Revenue Forecast, 2020-2030
14.7 Covid-19 Impact on Middle East & Africa Ophthalmic Drugs Market
14.7.1 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.2 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.3 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.4 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.5 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.6 U-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.7 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.8 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.9 V-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.9.1 V-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.9.2 V-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.9.3 V-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.9.4 V-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.9.5 V-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.9.6 V-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.10 UShaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.10.1 U-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.10.2 U-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.10.3 U-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.10.4 U-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.10.5 U-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.10.6 U-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.11 L-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.11.1 L-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.11.2 L-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.11.3 L-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.11.4 L-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.11.5 L-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.11.6 L-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.12 W-Shaped Recovery Middle East & Africa Ophthalmic Drugs Market, By Country: Market Forecast 2020-2030
14.7.12.1 W-Shaped Recovery Saudi Arabia Ophthalmic Drugs Market: Forecast 2020-2030
14.7.12.2 W-Shaped Recovery South Africa Ophthalmic Drugs Market: Forecast 2020-2030
14.7.12.3 W-Shaped Recovery UAE Ophthalmic Drugs Market: Forecast 2020-2030
14.7.12.4 W-Shaped Recovery Rest of MEA Ophthalmic Drugs Market: Forecast 2020-2030
14.7.12.5 W-Shaped Recovery South Korea Ophthalmic Drugs Market: Forecast 2020-2030
14.7.12.6 W-Shaped Recovery Rest of Middle East & Africa Ophthalmic Drugs Market: Forecast 2020-2030

** This section includes the detailed analysis of Middle East & Africa ophthalmic drugs market size and forecast for by indication, by type, by distribution channel and by country (Saudi Arabia, South Africa, UAE, Rest of Middle East & Africa)

15. Leading Companies in the Vaccine Contract Manufacturing Market, 2020-2030
15.1 Pre-Covid Leading Companies in the Ophthalmic Drugs Market, 2020
15.2 Novartis
15.2.1 Novartis: Ophthalmic Drugs Portfolio
15.2.2 Novartis AG: Financial Overview
15.2.3 Novartis: Sales Forecast, 2020-2030
15.2.4 Novartis: Ophthalmic Drugs Development Pipeline
15.2.5 Novartis: Recent Developments
15.3 Regeneron
15.3.1 Regeneron: Ophthalmic Drugs Portfolio
15.3.2 Regeneron: Financial Overview
15.3.3 Regeneron: Sales Forecast, 2020-2030
15.3.4 Regeneron: Ophthalmic Drugs Development Pipeline
15.3.5 Regeneron: Recent Developments
15.4 Allergan
15.4.1 Allergan: Financial Overview
15.4.2 Allergan: Sales Forecast, 2020-2030
15.4.3 Allergan: Ophthalmic Drugs Development Pipeline
15.4.4 Allergan: Recent Developments
15.5 Roche
15.5.1 Roche: Ophthalmic Drugs Portfolio
15.5.2 Roche: Financial Overview
15.5.3 Roche: Sales Forecast, 2020-2030
15.5.4 Roche: Ophthalmic Drugs Development Pipeline
15.5.5 Roche: Recent Developments
15.6 Santen Pharmaceutical Co.
15.6.1 Santen: Ophthalmic Drugs Portfolio
15.6.2 Santen: Financial Overview
15.6.3 Santen: Sales Forecast, 2020-2030
15.6.4 Santen: Ophthalmic Drugs Development Pipeline
15.6.5 Santen: Recent Developments
15.7 Bayer
15.7.1 Bayer: Ophthalmic Drugs Portfolio
15.7.2 Bayer: Financial Overview
15.7.3 Bayer: Financial Overview
15.8 Pfizer
15.8.1 Pfizer: Ophthalmic Drugs Portfolio
15.8.2 Pfizer: Financial Overview
15.8.3 Pfizer: Sales Forecast, 2020-2030
15.8.4 Pfizer: Ophthalmic Drugs Development Pipeline
15.8.5 Pfizer: Recent Developments
15.9 Senju Pharmaceutical Company Ltd (Senju)
15.9.1 Senju: Ophthalmic Drugs Portfolio
15.9.2 Senju: Ophthalmic Drugs Development Pipeline
15.9.3 Senju: Sales Forecast, 2020-2030
15.9.4 Senju: Recent Developments
15.10 Bausch Health Companies Inc.
15.10.1 Bausch Health Companies Inc.: Ophthalmic Drugs Portfolio
15.10.2 Bausch Health Companies Inc. AG: Financial Overview
15.10.3 Bausch Health: Sales Forecast, 2020-2030
15.10.4 Bausch Health Companies Inc: Ophthalmic Drugs Development Pipeline
15.10.5 Bausch Health Companies Inc.: Recent Developments
15.11 Akorn, Inc.
15.11.1 Akorn, Inc.: Ophthalmic Drugs Portfolio
15.11.2 Akorn, Inc. AG: Financial Overview
15.11.3 Akorn, Inc.: Sales Forecast, 2020-2030
15.11.4 Akorn, Inc.: Recent Developments
15.12 Sun Pharmaceutical Industries Ltd.
15.12.1 Sun Pharmaceutical Industries Ltd.: Ophthalmic Drugs Portfolio
15.12.2 Sun Pharmaceutical Industries Ltd. AG: Financial Overview
15.12.3 Sun Pharmaceutical: Ophthalmic Drugs Development Pipeline
15.12.4 Sun Pharmaceutical Industries Ltd. : Recent Developments
15.13 Aerie Pharmaceuticals Inc
15.13.1 Aerie Pharmaceuticals Inc.: Ophthalmic Drugs Portfolio
15.13.2 Aerie Pharmaceuticals Inc. AG: Financial Overview
15.13.3 Aerie Pharmaceuticals: Ophthalmic Drugs Development Pipeline
15.13.4 Aerie Pharmaceuticals Inc.: Recent Developments
15.14 Biogen
15.14.1 Biogen Inc.: Ophthalmic Drugs Portfolio
15.14.2 Biogen AG: Financial Overview
15.14.3 Biogen: Recent Developments

** This section includes the detailed company profile including company overview, ophthalmic drugs portfolio, financial details, recent developments in the ophthalmic drugs market segment

16. Ophthalmic Drugs: Research and Development Pipeline, 2020-2030
16.1 The Ophthalmic Drugs Pipeline: Intensive Development Efforts in Retinal Disorders
16.2 Drugs for Retinal Disorders: Development Pipeline
16.2.1 Will Bevasiranib (RXi Pharmaceuticals) Resume Development?
16.3 Retinal Disorders: Filed or Recently Launched
16.3.1 Beovu (brolucizumab) - Novartis
16.3.2 CompaqSipp (conbercept) - Chengdu Kanghong Pharmaceutical
16.3.3 Lipidil (fenofibrate) - Abbott
16.3.4 luvien (fluocinolone) - Alimera Sciences
16.4 Drugs in Phase 3 Development for Retinal Disorders
16.4.1 AGN150998 and MP0260 (Anti-VEGFDARPins) - Allergan
16.4.2 Fovista and Zimura - Ophthotech Corporation
16.4.3 Lampalizumab (anti-FactorD Fab) - Roche
16.4.4 MC-1101 (hydralazine) - Macu CLEAR
16.4.5 Squalamine (anti-angiogenic drug) - OHRPharmaceutical
16.4.6 Tandospirone (serotonin 1A agonist) - Alcon (Novartis)
16.4.7 UF-021 (unoprostone) - R-TechUeno
16.5 Drugs in Phase 2 Development for Retinal Disorders
16.5.1 AKB-9778 (Tie2 activator) - AerpioTherapeutics
16.5.2 Luminate (ALG-1001; Integrin peptide therapy) - Allegro/Senju
16.5.3 AGN208397 (beclomethasone) - Allergan
16.5.4 CPC 551 - ColbyPharmaceutical
16.5.5 ESBA1008 (anti-VEGF mAb) - Alcon (Novartis)
16.5.6 iCo-007 (antisense inhibitor of C-raf kinase mRNA) - iCo Therapeutics
16.5.7 LFG316 (anti-C5 mAb) - Novartis
16.5.8 Intravitreal brimonidine implant - Allergan
16.5.9 Optina (danazol) - Ampio Pharmaceuticals
16.5.10 PF-655 (synthetic siRNA) - Quark/Pfizer
16.5.11 Premiplex (SHP-607) - Shire
16.5.12 Renexus (ciliary neurotrophic factor) - Neurotech
16.5.13 Zybrestat (fosbretabulin) - Oxigene/SymphonyVIDA
16.6 Drugs In Phase 1 and Pre-clinical Developmentfor Retinal Disorders
16.6.1 BDM-E - BioDiem
16.6.2 NADPHOxidaseInhibitors - AlimeraSciences
16.6.3 PAN-90806 (topical VEGF inhibitor) - PanOptica
16.6.4 QLT091001 (synthetic retinoid) - QLT
16.6.5 PlasmaKallikreinInhibitors (KVD001) - KalVista
16.7 Drugs in Phase 3 Development for Allergic, Inflammatory and Infective Ophthalmic Conditions
16.7.1 EGP-437 (dexamethasone) - EyeGate Pharmaceuticals
16.7.2 IBI-10090 and IBI-20089 - IconBioscience
16.7.3 KPI-121 (loteprednol etabonate) - Kala
16.8 Drugs in Phase 2 Development for Allergic, Inflammatory And Infective Ophthalmic Conditions
16.8.1 CF101 (adenosine A3 receptor agonist) - Can-Fite BioPharma and OphthaliX
16.8.2 FST-100 (povidone-iodine/dexamethasone) - Shire
16.8.3 NVC-422 (auriclosene) - NovaBay
16.8.4 Sarilumab - Regeneron
16.9 Drugs in Phase 1 and Pre-clinical Development for Allergic, Inflammatory and Infective Ophthalmic Conditions
16.9.1 Finafloxacin - MerLion Pharmaceuticals/Novartis
16.10 Drugs for Glaucoma: Development Pipeline, 2020
16.11 Drugs in Phase 2&3 Development for Glaucoma
16.11.1 Latanoprostene Bunod (VESNEO; BOL 303259-X) - Valeant
16.11.2 AMA0076 (ROCK inhibitor) - Amakem
16.11.3 Rhopressa (AR-13324; ROCK and NET inhibitor) AndRoclatan (PG324; ROCK inhibitor) - Aerie Pharmaceuticals
16.12 Drugs in Phase 1 and Pre-clinical Development for Glaucoma
16.13 Drugs in Phase 3 Development for Dry Eye
16.13.1 EBI-005 (IL-1R antagonist) - Eleven Biotherapeutics
16.13.2 Lifitegrast (integrin antagonist) - Shire
16.13.3 Tavilermide (formerly MIM-D3tyrosine kinase receptor antagonist) - Allergan
16.14 ESBA105 (TNF-alpha antibody) - Alcon (Novartis)
16.15 Kineret (anakinra: IL-1 receptor antagonist) - Amgen/Sobi
16.16 Other Drugs in the Development Pipeline for Ophthalmic Conditions
16.16.1 Brimonidine For Eye Whitening - Valeant
16.16.2 GS-101 (aganirsen) - GeneSignal
16.16.3 Omidria (phenylephrine/ketorolac) - Omeros

17. Conclusions
17.1 Overview of Current Market Conditions and Market Forecast, 2020-2030
17.2 Leading Regions in the Ophthalmic Drugs Market in 2020
17.3 Leading Companies in the Ophthalmic Drugs Market, 2020
17.4 What Does the Future Hold for Ophthalmic Drugs?

List of Tables
Table 1 Report Summary
Table 2 ICD-10 Classification of Visual Impairment, 2017
Table 3 Classification of Glaucoma
Table 4 Drug Treatments for AMD, 2020
Table 5 Drug Treatments for Ocular Allergy, 2020
Table 6 Drug Treatments for Ocular Inflammatory Disease, 2020
Table 7 Selected Drug Treatments for Eye Infections, 2020
Table 8 Clinical Trial Phases
Table 9 SWOT Analysis of the Global Ophthalmic Drugs Market, 2020-2030
Table 10 World 65+ Population Forecast: Size (m), AGR (%), 2017-2028
Table 11 Global Prevalence Forecast for Ophthalmic Diseases
Table 12 PESTEL Analysis of the Global Ophthalmic Drugs Market, 2020-2030
Table 13 Global Ophthalmic Drugs Market Snapshot, 2020 & 2030 (US$ Mn, CAGR %)
Table 14 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 15 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 16 Pre-Covid Global ophthalmic drugs market by Indication: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 17 V-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 18 U-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 19 L-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 20 W-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 21 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 22 Global ophthalmic drugs market by type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 23 V-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 24 U-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 25 L-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 26 W-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 27 Pre-Covid Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 28 V-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 29 U-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 30 L-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 31 W-Shaped Recovery Global prescription drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 32 Pre-Covid Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 33 V-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 34 U-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 35 L-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 36 W-Shaped Recovery Global OTC drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 37 Pre-Covid Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 38 Global ophthalmic drugs market by type: CAGR (%), 2020-2025, 2025-2030, 2020-2030
Table 39 V-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 40 U-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 41 L-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 42 W-Shaped Recovery Global ophthalmic drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 43 Pre-Covid Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 44 V-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 45 U-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 46 L-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 47 W-Shaped Recovery Global hospital pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 48 Pre-Covid Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 49 V-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 50 U-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 51 L-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 52 W-Shaped Recovery Global drug stores market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 53 Pre-Covid Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 54 V-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 55 U-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 56 L-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 57 W-Shaped Recovery Global online pharmacies market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 58 Global Retinal Disorder Drugs Market by Drugs, 2020
Table 59 Pre-Covid Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 60 V-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 61 U-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 62 L-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 63 W-Shaped Recovery Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 64 Pre-Covid Global Retinal Disorder Drugs market forecast: revenues ($ m), AGR (%), CAGR (%), 2020-2030
Table 65 Global Retinal Disorder Drugs mark

この商品のレポートナンバー

0000028866

TOP